• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

The mechanism of bile duct destruction in Primary Biliary Cirrhosis

Research Project

  • PDF
Project/Area Number 22590739
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKyushu University

Principal Investigator

SHIMODA Shinji  九州大学, 大学病院, 講師 (30279319)

Project Period (FY) 2010 – 2012
Keywords原発生胆汁性肝硬変 / 自然免疫 / モデルマウス
Research Abstract

Primary biliary cirrhosis (PBC) is characterized by chronic nonsuppurative destructive cholangitis (CNSDC) associated with destruction of small bile ducts. We examined the role of Toll-like receptors (TLRs), their ligands, and natural killer (NK) cells in modulating cytotoxic activity against biliary epithelial cells (BECs). We demonstrate that Toll-like receptor 4 ligand (TLR4-L)-stimulated NK cells destroy autologous BECs in the presence of interferon alpha (IFN-α) synthesized by TLR 3 ligand (TLR3-L)-stimulated monocytes (Mo). Indeed, IFN-α production by hepatic Mo is significantly increased in patients with PBC compared to disease controls. These data are supported by the immunohistochemical observation of an increased presence of CD56-positive NK cells scattered around destroyed small bile ducts more frequently in liver tissues from PBC patients than controls. To clarify the role of innate immune effector cells, such as natural killer (NK) cells, was studied in the mouse model based on the hypothesis that early events during immunization play an important role in the breakdown of tolerance. Following in-vivo depletion of NK cells, there is a marked suppression of anti-mitochondrial autoantibodies and cytokine production from autoreactive T cells. However, there was no change in the clinical pathology of portal inflammation compared to controls. These data support the hypothesis that there are probably multiple steps in the natural history of PBC, including a role of NK cells in initiating the breakdown of tolerance.

  • Research Products

    (20 results)

All 2012 2011 2010 Other

All Journal Article (11 results) (of which Peer Reviewed: 11 results) Presentation (8 results) Remarks (1 results)

  • [Journal Article] Vigorous cleaning and adequate ventilation are necessary to control an outbreak in a neonatal intensive care unit2012

    • Author(s)
      Shimono N, Hayashi J, Matsumoto H, Miyake N, Uchida Y, Shimoda S, Furusyo N, Akashi K
    • Journal Title

      J Infect Chemother

      Volume: 18(3) Pages: 303-7

    • Peer Reviewed
  • [Journal Article] Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis2011

    • Author(s)
      Mitchell MM, Lleo A, Zammataro L, Mayo MJ, Invernizzi P, Bach N, Shimoda S, Gordon S, Podda M, Gershwin ME, Selmi C, LaSalle JM
    • Journal Title

      Epigenetics

      Volume: 6(1) Pages: 95-102

    • Peer Reviewed
  • [Journal Article] Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3a in the pathogenesis of primary biliary cirrhosis2011

    • Author(s)
      Harada K, Shimoda S, Ikeda H, Chiba M, Hsu M, Sato Y, Kobayashi M, Ren XS, Ohta H, Kasashima S, Kawashima A, Nakanuma Y
    • Journal Title

      Liver Int

      Volume: 31(2) Pages: 245-53

    • Peer Reviewed
  • [Journal Article] Intracellular B7-H4 suppresses bile duct epithelial cell apoptosis in human primary biliary cirrhosis2011

    • Author(s)
      Chen Y, Guo G, Guo S, Shimoda S, Shroyer KR, Tang Y, Wu Y
    • Journal Title

      Inflammation

      Volume: 34(6) Pages: 688-97

    • Peer Reviewed
  • [Journal Article] Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis2011

    • Author(s)
      Shimoda S, Harada K, Niiro H, Shirabe K, Taketomi A, Maehara Y, Tsuneyama K, Nakanuma Y, Leung P, Ansari AA, Gershwin ME, Akashi K
    • Journal Title

      Hepatology

      Volume: 53(4) Pages: 1270-81

    • Peer Reviewed
  • [Journal Article] Modulation of CD4 T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis2011

    • Author(s)
      Hashimoto N, Shimoda S, Kawanaka H, Tsuneyama K, Uehara H, Akahoshi T, Kinjo N, Taketomi A, Shirabe K, Akashi K, Lleo A, Ansari AA, Gershwin ME, Maehara Y
    • Journal Title

      Clin Exp Immunol

      Volume: 165(2) Pages: 243-50

    • Peer Reviewed
  • [Journal Article] Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis2011

    • Author(s)
      Tsuda M, Ambrosini YM, Zhang W, Yang GX, Ando Y, Rong G, Tsuneyama K, Sumida K, Shimoda S, Bowlus CL, Leung PS, He XS, Coppel RL, Ansari AA, Lian ZX, Gershwin ME
    • Journal Title

      Hepatology

      Volume: 54(4) Pages: 1293-302

    • Peer Reviewed
  • [Journal Article] Serum BAFF and APRIL levels in patients with PBC2010

    • Author(s)
      Migita K, Ilyassova B, Kovzel EF, Nersesov A, Abiru S, Maeda Y, Komori A, Ito M, Yano K, Yatsuhashi H, Shimoda S, Ishibashi H, Nakamura M
    • Journal Title

      Clin Immunol.Feb

      Volume: 134(2) Pages: 217-25

    • Peer Reviewed
  • [Journal Article] a signpost for biliary inflammation in primary biliary cirrhosis2010

    • Author(s)
      Shimoda S, Harada K, Niiro H, Taketomi A, Maehara Y, Tsuneyama K, Kikuchi K, Nakanuma Y, Mackay IR, Gershwin ME, Akashi K CX3CL1 (fractalkine)
    • Journal Title

      Hepatology. Feb

      Volume: 51(2) Pages: 567-75

    • Peer Reviewed
  • [Journal Article] Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC) The HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC2010

    • Author(s)
      Nakamura M, Yasunami M, Kondo H, Horie H, Aiba Y, Komori A, Migita K, Yatsuhashi H, Ito M, Shimoda S, Ishibashi H; PBC Study Group in NHOSLJ
    • Journal Title

      Hepatol Res. May

      Volume: 40(5) Pages: 494-504

    • Peer Reviewed
  • [Journal Article] Kyushu University Liver Disease Study Group.Pegylated interferon a-2b plus ribavirin for older patients with chronic hepatitis2010

    • Author(s)
      Kainuma M, Furusyo N, Kajiwara E, Takahashi K, Nomura H, Tanabe Y, Satoh T, Maruyama T, Nakamuta M, Kotoh K, Azuma K, Shimono J, Shimoda S, Hayashi J
    • Journal Title

      C. World J Gastroenterol

      Volume: 16(35) Pages: 4400-9

    • Peer Reviewed
  • [Presentation] 原発性胆汁性肝硬変における病因病態の解析2012

    • Organizer
      日本肝臓学会大会
    • Year and Date
      2012-10-20
  • [Presentation] 原発性胆汁性肝硬変における胆管上皮の疾患特異的自己抗原発現条件の探索2012

    • Organizer
      日本肝臓学会総会
    • Year and Date
      2012-06-07
  • [Presentation] 原発性胆汁性肝硬変モデルマウスにおけるNK/NKT細胞の役割2012

    • Organizer
      日本消化器病学会
    • Year and Date
      2012-04-19
  • [Presentation] 原発性胆汁性肝硬変における胆管破壊に関する新規知見2011

    • Organizer
      日本肝臓学会総会
    • Year and Date
      2011-06-02
  • [Presentation] 原発性胆汁性肝硬変の病態解明と新規治療の可能性2011

    • Organizer
      日本消化器病学会
    • Year and Date
      2011-05-13
  • [Presentation] 原発性胆汁性肝硬変(PBC)における免疫異常の基礎とそれに基づく予後予測について2010

    • Organizer
      日本肝臓学会大会
    • Year and Date
      2010-10-13
  • [Presentation] 原発性胆汁性肝硬変における胆管CX3CL1発現に必要なTNFaは、主にTLR4リガンドで単球から産生される2010

    • Organizer
      日本肝臓学会総会
    • Year and Date
      2010-05-27
  • [Presentation] 原発性胆汁性肝硬変における CX3CL1 産生の機序2010

    • Organizer
      日本消化器病学会総会
    • Year and Date
      2010-04-23
  • [Remarks]

    • URL

      http://www.1nai.med.kyushu-u.ac.jp/

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi